Company Filing History:
Years Active: 2019-2020
Title: Hanlin Tao: Innovator in Metabolic Disease Treatment
Introduction
Hanlin Tao is a prominent inventor based in Branchburg, NJ (US). He has made significant contributions to the field of metabolic disease treatment through his innovative research and patented inventions. With a total of 2 patents, Tao is dedicated to advancing medical science and improving patient outcomes.
Latest Patents
Tao's latest patents focus on mitochondrial uncouplers for the treatment of metabolic diseases and cancer. One of his notable inventions is the 2-hydroxy-benzoic anilide compounds and derivatives, which include compositions and methods for treating metabolic diseases and cancer through the uncoupling of mitochondria. Another patent involves benzamide compounds and their prodrugs, which are used in pharmaceutical compositions for treating diseases related to lipid metabolism, such as diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD). These inventions also address conditions caused by abnormal cell proliferation, including cancer and psoriasis.
Career Highlights
Hanlin Tao is affiliated with Rutgers, the State University of New Jersey, where he conducts his research and develops his innovative solutions. His work has garnered attention for its potential impact on treating serious health conditions.
Collaborations
Tao collaborates with esteemed colleagues, including Shengkan Jin and David John Augeri, to further enhance the scope and effectiveness of his research.
Conclusion
Hanlin Tao's contributions to the field of metabolic disease treatment through his innovative patents highlight his commitment to advancing medical science. His work has the potential to significantly improve the lives of individuals affected by these conditions.